Skip to content
Screener

Danaher DHR Diagnostics — Goodwill, Foreign Currency Translation, Gain (Loss)

Other segment segments

Life Sciences
$135.5M+374%

Similar metrics at other companies

Bio-Rad Laboratories logo
BIOClinical Diagnostics — Goodwill, Foreign Currency Translation, Gain (Loss)
$0-100%
TTC
TTCProfessional — Goodwill, Foreign Currency Translation, Gain (Loss)
$3.6M+820%
TTC
TTCResidential — Goodwill, Foreign Currency Translation, Gain (Loss)
$0-100%
Campbell Soup logo
CPBSnacks — Goodwill, Foreign Currency Translation, Gain (Loss)
$0
Amentum Holdings logo
AMTMDS — Goodwill, Foreign Currency Translation, Gain (Loss)
$0
Amentum Holdings logo
AMTMGES — Goodwill, Foreign Currency Translation, Gain (Loss)
-$250K

Other financials

Income statement

See full
Revenue$6.3B+5.5%
Gross profit$3.6B+2.5%
Operating income$1.1B+48.3%
Net income$870.0M+56.8%
EPS (diluted)$1.23+59.7%

Balance sheet

See full
Cash & equivalents$4.3B+47.0%
Total debt$27.9B+50.1%
Total equity$52.6B+0.5%
Total assets$92.4B+13.2%

Cash flow

See full
Operating cash flow$1.5B+14.6%
CapEx$269.0M+8.5%
Free cash flow$1.3B+16.1%

Valuation

See full
Market cap$140.36B+0.4%
Enterprise value$163.87B+5.5%
P/E35.1×-5.9×
P/S5.6×-0.2×

Profitability

See full
Gross margin58.5%-1.1pp
Operating margin20.4%+2.0pp
Net margin15.9%+1.7pp
FCF margin21.8%+1.5pp

Returns & leverage

See full
Return on equity7.6%+1.0pp
Debt / equity0.5×+0.2×
Current ratio1.7×0.0×

Where this comes from

Reported directly by Danaher in its filing.

Tagged under the XBRL concept us-gaap:GoodwillForeignCurrencyTranslationGainLoss.

The source filing: Danaher’s 10-K, filed February 24, 2026.

Filed
Feb 24, 2026, 4:36 PM EST
Fiscal year
FY2025
Accession
0000313616-26-000062
Line itemBiotechnologyLife SciencesDiagnosticsTotal
Balance, January 1, 2024$22,477$12,221$6,910$41,608
Attributable to 2024 acquisitions305305
Adjustments due to finalization of purchase price adjustments(23)(23)
Foreign currency translation and other(1,040)(198)(155)(1,393)
Balance, December 31, 202421,43712,3056,75540,497
Adjustments due to finalization of purchase price allocations99
Foreign currency translation and other1,8765422272,645
Balance, December 31, 2025$23,313$12,856$6,982$43,151

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

FAQ

What is Danaher's diagnostics — goodwill, foreign currency translation, gain (loss)?
Danaher (DHR) reported diagnostics — goodwill, foreign currency translation, gain (loss) of $56.75M in Q4 2025.
How has Danaher's diagnostics — goodwill, foreign currency translation, gain (loss) changed year-over-year?
Danaher's diagnostics — goodwill, foreign currency translation, gain (loss) increased by 246.5% year-over-year, from -$38.75M to $56.75M.
What is the long-term trend for Danaher's diagnostics — goodwill, foreign currency translation, gain (loss)?
Over 3 years (2021 to 2025), Danaher's diagnostics — goodwill, foreign currency translation, gain (loss) has grown at a 15.3% compound annual growth rate (CAGR), from -$148M to $227M.
What does diagnostics — goodwill, foreign currency translation, gain (loss) mean?
This metric captures the impact of fluctuations in foreign exchange rates on the carrying value of goodwill denominated in currencies other than the reporting currency for the Diagnostics segment. It reflects the translation of goodwill from the functional currency of foreign subsidiaries into the consolidated reporting currency. This is a non-cash item that highlights the segment's exposure to international market currency volatility.

Ask your AI about Danaher's diagnostics — goodwill, foreign currency translation, gain (loss).

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude